National Brain Tumor Society Appoints David Arons as CEO
November 30, 2015 The National Brain Tumor Society, a national nonprofit based in Newton that supports the brain tumor community through research and advocacy and works to improve the pace of drug discovery and development, recently announced that David Arons has been named chief executive officer after filling the role on an interim basis since July.
He succeeds Sally Davis, who stepped down after serving less than a year in the post.
Michael Nathanson, board chair of the National Brain Tumor Society
(NBTS), said, National Brain Tumor Society has a great and unique responsibility to our constituents; and we firmly believe that David has the deep skills and experience necessary to meet that obligation.
Davids extensive work and experience in the field of cancer research, combined with his unparalleled track record as a healthcare advocate, are only bolstered by his many years of direct experience leading the fight against brain tumors while at the National Brain Tumor Society.
Arons will be responsible for ensuring alignment with NBTS vision and strategic plan and oversee the organizations fundraising, internal, and external operations, and programmatic initiatives.
The status quo in brain tumors is totally unacceptable, said Arons. As a community we need to be even more demanding for new and effective treatments, and ultimately cures, for both adults and children with brain tumors. Moving forward, NBTS will remain laser focused on advancing research and our objective to make malignant brain tumors a chronic manageable disease in ten years.
Arons lauded Davis for managing the restructuring and realignment of the organizations staff and departments, which will be critical to the future success and growth of NBTS
Prior to being appointed as the interim CEO, Arons had served as chief public policy and advocacy officer at NBTS since 2011, directing NBTSs federal and state public policy and government affairs efforts, including its national advocacy program.
Earlier, he served as director of government relations for the American Cancer Society in Minnesota and co-executive director of Center for Lobbying in the Public Interest.
He is the author of several books, including Power in Policy: A Funders Guide to Advocacy and Civic Participation, Strengthening Nonprofit Advocacy
, and A Voice for Nonprofits
He also serves as chair of the National Cancer Institutes Council of Research Advocates and is a member of the NCIs Clinical Trials Advisory Committee.
Arons earned a Bachelor of Science degree in political science from James Madison University, a Master of Arts degree in public policy from Tufts University, and a Juris Doctor degree from William Mitchell College of Law.
According to NBTS, 688,000 Americans are living with a brain tumor and an estimated 68,470 people will receive primary brain tumor diagnoses this year. The average survival rate for all malignant brain tumor patients is 34.2%.